Literature DB >> 15502967

Beta-adrenergic receptor density and adenylate cyclase activity in lead-exposed rat brain after cessation of lead exposure.

Huoy-Rou Chang1, Der-An Tsao, Hsin-Su Yu, Chi-Kung Ho.   

Abstract

To understanding the reversible or irreversible harm to the beta-adrenergic system in the brain of lead-exposed rats, this study sets up an animal model to estimate the change in the sympathetic nervous system of brain after lead exposure was withdrawn. We address the following topics in this study: (a) the relationship between withdrawal time of lead exposure and brain beta-adrenergic receptor, blood lead level, and brain lead level in lead-exposed rats after lead exposure was stopped; and (b) the relationship between lead level and beta-adrenergic receptor and cyclic AMP (c-AMP) in brain. Wistar rats were chronically fed with 2% lead acetate and water for 2 months. Radioligand binding was assayed by a method that fulfilled strict criteria of beta-adrenergic receptor using the ligand [125I]iodocyanopindolol. The levels of lead were determined by electrothermal atomic absorption spectrometry. The c-AMP level was determined by radioimmunoassay. The results showed a close relationship between decreasing lead levels and increasing numbers of brain beta-adrenergic receptors and brain adenylate cyclase activity after lead exposure was withdrawn. The effect of lead exposure on the beta-adrenergic system of the brain is a partly reversible condition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502967     DOI: 10.1007/s00204-004-0605-9

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  1 in total

1.  Heart rate variability and peripheral nerve conduction velocity in relation to blood lead in newly hired lead workers.

Authors:  Cai-Guo Yu; Fang-Fei Wei; Wen-Yi Yang; Zhen-Yu Zhang; Blerim Mujaj; Lutgarde Thijs; Ying-Mei Feng; Jan A Staessen
Journal:  Occup Environ Med       Date:  2019-03-30       Impact factor: 4.402

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.